drugset / Trial / NCT05517681

Application of ICG in Lymph Node Dissection During Radical Resection of Rectal Cancer With Preserved Autonomic Nerves Around LCA and IMA

NCT05517681 ↗

Completed 96 enrolled The First Hospital of Qinhuangdao
RandomizedParallel-groupDouble-blindPrevention

Summary

Indocyanine green NIR imaging is valuable for lymph node dissection in D3 radical surgery for rectal cancer. It can guide the intraoperative improvement of lymph node dissection based on the preservation of LCA and peripheral autonomic nerves of IMA. This not only reduces the occurrence of postoperative complications and promotes rapid postoperative recovery, but also provides a more precise and individualized comprehensive treatment plan for patients after surgery. In addition,this trial also demonstrated that ICG is safe and feasible for use in rectal cancer

Timeline

Start
2020-09-07
Primary completion
2022-07-10
Completion
2022-07-10

Drugs

EvaluationDrugModalityDoseRoute
Subject ICG Diagnostic / imaging agent 2.5 mg/ml Other

Indications

No indication recorded.